Dynamic modulation changes of POMC in the arcuate nucleus and neuroendocrine adaptation in response to lifestyle intervention in obese adults

[1] Bombassaro B, Araujo EP, Velloso LA.The hypothalamus as the central regulator of energy balance and its impact on current and future obesity treatments.Archives of Endocrinology and Metabolism. 2024;68(special issue).10.20945/2359-4292-2024-0082

[2] Brüning JC, Fenselau H. Integrative neurocircuits that control metabolism and food intake. Science. 2023;381(6665).10.1126/science.abl7398

[3] Chen X, Wang Y, Fu S, Wan Y, Mao J, Cui K, et al. The Integrated Function of the Lateral Hypothalamus in Energy Homeostasis. Cells. 2025;14(14):1042.10.3390/cells14141042

[4] Song J, Choi SY. Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases. Experimental Neurobiology. 2023;32(6):371–386. 10.5607/en23040

[5] Rezaieg NS, Awad MM. Neurophysiology and Endocrine Responses to Hunger and Satiety Mechanisms: The Brain-Gut Crosstalk. Karbala International Journal of Modern Science. 2025;11(3). 10.33640/2405-609x.3416

[6] Qi Y, Lee NJ, Ip CK, Enriquez R, Tasan R, Zhang L, et al. Agrp-negative arcuate NPY neurons drive feeding under positive energy balance via altering leptin responsiveness in POMC neurons. Cell Metabolism. 2023;35(6):979–995.e7. 10.1016/j.cmet.2023.04.020

[7] Hu H, Lu X, He Y, Li J, Wang S, Luo Z, et al.Sestrin2 in POMC neurons modulates energy balance and obesity related metabolic disorders via mTOR signaling.The Journal of Nutritional Biochemistry. 2024;133:109703.10.1016/j.jnutbio.2024.109703

[8] Quiñones M, Hernández-Bautista R, Beiroa D, Heras V, Torres-Leal FL, Lam BYH, et al. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner. Redox Biology. 2021;41:101945.10.1016/j.redox.2021.101945

[9] Xing M, Li Y, Zhang Y, Zhou J, Ma D, Zhang M, et al. Paraventricular hypothalamic RUVBL2 neurons suppress appetite by enhancing excitatory synaptic transmission in distinct neurocircuits.Nature Communications. 2024;15(1).10.1038/s41467-024-53258-6

[10] Clarke GS, Page AJ, Eldeghaidy S.The gut–brain axis in appetite, satiety, food intake, and eating behavior: Insights from animal models and human studies. Pharmacology Research & Perspectives. 2024;12(5).10.1002/prp2.70027

[11] Rafiei N, Mitchell CS, Tedesco CR, Chen J, Choi EA, Roughley S, et al. Chemogenetic activation of arcuate nucleus NPY and NPY/AgRP neurons increases feeding behaviour in mice.Neuropeptides. 2024;107:102454.10.1016/j.npep.2024.102454

[12] Liskiewicz A, Khalil A, Liskiewicz D, Novikoff A, Grandl G, Maity-Kumar G, et al.Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice.Nature Metabolism. 2023;5(12):2075–2085. 10.1038/s42255-023-00931-7

[13] Roh E, Choi KM. Hormonal Gut–Brain Signaling for the Treatment of Obesity. International Journal of Molecular Sciences. 2023;24(4):3384. 10.3390/ijms24043384

[14] Kim N, Kim S, Park S, Kim EK.Adenosine transmission from hypothalamic tanycytes to AGRP/NPY neurons regulates energy homeostasis.Experimental & Molecular Medicine. 2025;57(5):1047–1063. 10.1038/s12276-025-01449-6

[15] Liu W, Li N, Tang D, Qin L, Zhu Z.Multimodal Neuroimaging of Obesity: From Structural-Functional Mechanisms to Precision Interventions.Brain Sciences. 2025;15(5):446.10.3390/brainsci15050446

[16] Rezaieg NS.Neurobiology of Sweet Cravings: The Brain’s Reward System Response to Hedonic Eating. Kufa Medical Journal. 2024;20(2):135–146. 10.36330/kmj.v20i2.17199

[17] Song X, Qian Y. The activation and regulation of IL-17 receptor mediated signaling. Cytokine. 2013;62(2):175–182.10.1016/j.cyto.2013.03.014

[18] Capocasa M, Venier D. A bio-cultural tale of the past, present and future of human nutrition. Journal of anthropological sciences. 2024;102:87-104

[19] Johnson-Mann CN, Cupka JS, Ro A, Davidson AE, Armfield BA, Miralles F, et al. A Systematic Review on Participant Diversity in Clinical Trials—Have We Made Progress for the Management of Obesity and Its Metabolic Sequelae in Diet, Drug, and Surgical Trials. Journal of Racial and Ethnic Health Disparities. 2022;10(6):3140–3149. 10.1007/s40615-022-01487-0

[20] Ariyani W, Yoshikawa C, Tsuneoka H, Amano I, Imayoshi I, Ichinose H, et al. Dopaminergic neurons in the paraventricular hypothalamus extend the food consumption phase. Proceedings of the National Academy of Sciences. 2025;122(13). 10.1073/pnas.2411069122

[21] Huwart SJP, Morales-Puerto N, Everard A. Gut microbiota-related neuroinflammation at the crossroad of food reward alterations: implications for eating disorders.Gut. 2025;74(10):1728–1740. 10.1136/gutjnl-2024-333397

[22] Hankir MK, Lutz TA. Novel neural pathways targeted by GLP-1R agonists and bariatric surgery. Pflügers Archiv - European Journal of Physiology. 2024;477(2):171–185.10.1007/s00424-024-03047-3

[23] Min SH, Song DK, Lee CH, Roh E, Kim MS. Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator. Endocrinology and Metabolism. 2024;39(1):1–11. 10.3803/enm.2024.1922

[24] Quarta C, Claret M, Zeltser LM, Williams KW, Yeo GSH, Tschöp MH, et al. POMC neuronal heterogeneity in energy balance and beyond: an integrated view. Nature Metabolism. 2021;3(3):299–308. 10.1038/s42255-021-00345-3

[25] Al-Suhaimi EA, AlRubaish AA, Aldossary HA, Homeida MA, Shehzad A, Homeida AM.Obesity and Cognitive Function: Leptin Role Through Blood–Brain Barrier and Hippocampus. Molecular Neurobiology. 2025;62(12):16280–16301. 10.1007/s12035-025-05262-0

[26] Della Guardia L, Shin AC. Obesity-induced tissue alterations resist weight loss: A mechanistic review. Diabetes, Obesity and Metabolism. 2024;26(8):3045–3057.10.1111/dom.15637

[27] Wulff BS, Kuhre RE, Selvaraj M, Rehfeld JF, Niss K, Fels JJ, et al. Improved leptin sensitivity and increased soluble leptin receptor concentrations may underlie the additive effects of combining PYY(3–36) and exendin-4 on body weight lowering in diet-induced obese mice.Heliyon. 2024;10(12):e32009. 10.1016/j.heliyon.2024.e32009

[28] Mitoiu BI, Nartea R, Miclaus RS. Impact of Resistance and Endurance Training on Ghrelin and Plasma Leptin Levels in Overweight and Obese Subjects. International Journal of Molecular Sciences. 2024;25(15):8067.10.3390/ijms25158067

[29] Brandt-Heunemann S, Vogel M, Kiess W, Körner A, Blüher M, Meigen C, et al. Reference Values for Serum Leptin Levels in Children, Adolescents, and Adults With Normal Weight, Overweight, and Obesity. The Journal of Clinical Endocrinology & Metabolism. 2025;111(3):832–844. 10.1210/clinem/dgaf439

[30] Wang Y, Qi F, Li M, Xu Y, Dong L, Cai P.Traditional Chinese medicine modulates hypothalamic neuropeptides for appetite regulation: A comprehensive review. BioScience Trends. 2025;19(3):281–295. 10.5582/bst.2025.01087

[31] Rafey MF, Abdalgwad R, O’Shea PM, Foy S, Claffey B, Davenport C, et al. Changes in the Leptin to Adiponectin Ratio Are Proportional to Weight Loss After Meal Replacement in Adults With Severe Obesity. Frontiers in Nutrition. 2022;9. 10.3389/fnut.2022.845574

[32] Alic N, Ayaz A. Ghrelin and LEAP2: Their Interaction Effect on Appetite Regulation and the Alterations in Their Levels Following Bariatric Surgery. Medicina. 2025;61(8):1452. 10.3390/medicina61081452

[33] Sooriyaarachchi P, Jayawardena R, Pavey T, King NA.Meal Replacement as a Weight Loss Strategy for Night Shift Workers with Obesity: A Protocol for a Randomized Controlled Trial. Trials. 2022;23(1):860.10.1186/s13063-022-06784-x

[34] Karczewska-Kupczewska M, Stefanowicz M, Nikołajuk A, Strączkowski M. Weight-Reducing Dietary Intervention Increases the Ability of Hyperinsulinemia to Suppress Serum Ghrelin Concentration in Individuals with Obesity. The Journal of Nutrition. 2024;154(5):1631–1639. 10.1016/j.tjnut.2023.12.043

[35] Belli R, Dattolo A, Sampogna F, Gubinelli E, Lulli D, Moretta G, et al. Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.Frontiers in Immunology. 2025;16.10.3389/fimmu.2025.1607312

[36] Polak-Szczybyło E, Tabarkiewicz J.IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People.Nutrients. 2022;14(3):643.10.3390/nu14030643

[37] Alhamawi RM, Damfo S, Aloufi N, Almutawif YA, Suliman BA. Investigating the potential role of T helper 17 cells among women experiencing overweight and obesity and their possible therapeutic targeting of the RORγt molecule.Scientific Reports. 2024;14(1).10.1038/s41598-024-81070-1

[38] Zi C, Wang D, Gao Y, He L.The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone. Frontiers in Immunology. 2023;13.10.3389/fimmu.2022.1104943

[39] Artemniak-Wojtowicz D, Kucharska AM, Stelmaszczyk-Emmel A, Majcher A, Pyrżak B. Changes of Peripheral Th17 Cells Subset in Overweight and Obese Children After Body Weight Reduction. Frontiers in Endocrinology. 2022;13. 10.3389/fendo.2022.917402

[40] Sun CY, Yang N, Zheng ZL, Liu D, Xu QL.T helper 17 (Th17) cell responses to the gut microbiota in human diseases.Biomedicine & Pharmacotherapy. 2023;161:114483.10.1016/j.biopha.2023.114483

[41] JANICKA L, DAJNOWSKA A, ARCISZEWSKI MB.Role of Proopiomelanocortin (POMC) Derivatives in Body Weight Regulation: A Review of Current Knowledge and Significance in the Pathogenesis of Obesity in Mammals.Medycyna Weterynaryjna. 2025;81(5):221–230.10.21521/mw.6998

[42] Douglas A, Stevens B, Lynch L. Interleukin-17 as a key player in neuroimmunometabolism. Nature Metabolism. 2023;5(7):1088–1100. 10.1038/s42255-023-00846-3

[43] Hinte LC, Castellano-Castillo D, Ghosh A, Melrose K, Gasser E, Noé F, et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature. 2024;636(8042):457–465.10.1038/s41586-024-08165-7